Daniel E. Zak
0000-0002-1404-400X
Publication & Citation Trends
Publications
0 total
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing OA
Cited by 31
Semantic Scholar
Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis OA
Cited by 14
Semantic Scholar
T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice OA
Cited by 11
Semantic Scholar
The Peripheral Blood Transcriptome Is Correlated With PET Measures of Lung Inflammation During Successful Tuberculosis Treatment OA
Cited by 11
Semantic Scholar
Abstract 1582: T-SIGn cancer gene therapy and anti-EGFR CAR-T cells synergize in combination therapy to clear A549 lung tumor xenografts and lung metastases in NSG mice
Cited by 0
Semantic Scholar
Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis. OA
Cited by 100
Semantic Scholar
Apparent sterilizing immunity in BCG-immunized mice challenged with an ultra-low dose of Mycobacterium tuberculosis
Cited by 1
Semantic Scholar
The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection OA
Cited by 9
Semantic Scholar
Research Topics
Tuberculosis Research and Epidemiology
(31)
Mycobacterium research and diagnosis
(18)
vaccines and immunoinformatics approaches
(10)
Gene Regulatory Network Analysis
(9)
interferon and immune responses
(8)
Affiliations
Center for Infectious Disease Research
Biogen (United States)
Biotechnology Institute
Children’s Institute
Infectious Disease Research Institute